CalciMedica is trading at $0.74 (+6.59%) in after-hours trading, showing an idiosyncratic rebound despite a lack of company-specific news.
- No earnings releases, regulatory filings, or late-breaking catalysts were found to explain the upward move.
- The price action appears independent of broader market trends, as the Nasdaq Composite closed down 1.52% on July 16.